In this line, several studies demonstrated the negative prognostic value of RUNX1 co-mutations in SF3B1 mutated MDS [6, 12–14], thereby highlighting the role as potential driver gene associated with worse OS and a higher leukemic transformation rate within SF3B1 mutated patients [15]. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.